Epstein Secrets

y France Committee to the OECD Stuart Evans Chief Executive Officer Novacem United Kingdom Bob Every Chairman Wesfarmers Limited Australia Vladimir Evtushenkov Chairman of the Board of Directors Sistema JSFC Russian Federation Anna Ewing Executive Vice-President and Chief The NASDAQ OMX Group USA Inf

agement Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and General Director Mariinsky Theatre Russian Federation Valerie Germain Managing Partner

y France Committee to the OECD Stuart Evans Chief Executive Officer Novacem United Kingdom Bob Every Chairman Wesfarmers Limited Australia Vladimir Evtushenkov Chairman of the Board of Directors Sistema JSFC Russian Federation Anna Ewing Executive Vice-President and Chief The NASDAQ OMX Group USA Inf

agement Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and General Director Mariinsky Theatre Russian Federation Valerie Germain Managing Partner

pstein Mary Callahan Erdoes Charles W. Ergen Paula Escobar Patricia Espinosa Cantellano Shelly Esque Dan Esty John Evans Stuart Evans Bob Every Vladimir Evtushenkov Anna Ewing Jack Ewing Augie K. Fabela II David Faber Joachim Faber Carlos Jose Fadigas Jeffrey Fager Imad Fakhoury Nolitha V. Fakude Khalid A. Al

f Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Development Managing Director, Marketing Co-Founder and Chief Executive Officer